Abbott Laboratories (Pakistan) (KAR:ABOT) Accounts Payable & Accrued Expense : ₨6,675 Mil (As of Mar. 2025)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Accounts Payable & Accrued Expense?

Abbott Laboratories (Pakistan)'s quarterly accounts payable & accrued expense declined from Sep. 2024 (₨7,187 Mil) to Dec. 2024 (₨5,102 Mil) but then increased from Dec. 2024 (₨5,102 Mil) to Mar. 2025 (₨6,675 Mil).

Abbott Laboratories (Pakistan)'s annual accounts payable & accrued expense increased from Dec. 2022 (₨9,783 Mil) to Dec. 2023 (₨11,220 Mil) but then declined from Dec. 2023 (₨11,220 Mil) to Dec. 2024 (₨5,102 Mil).

Abbott Laboratories (Pakistan) Accounts Payable & Accrued Expense Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Accounts Payable & Accrued Expense Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

2,853.48

4,439.65

9,783.31

11,219.69

5,102.44

Abbott Laboratories (Pakistan) Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															9,385.84	8,253.10	7,186.99	5,102.44	6,675.29

Abbott Laboratories (Pakistan) Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Abbott Laboratories (Pakistan) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.

Abbott Laboratories (Pakistan) Headlines

No Headlines